|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martin-Hirsch PL and Wood NJ: Cervical
cancer. BMJ Clin Evid. Jul 27–2011.0818PubMed/NCBI
|
|
3
|
Duenas-Gonzalez A, Serrano-Olvera A,
Cetina L and Coronel J: New molecular targets against cervical
cancer. Int J Womens Health. 6:1023–1031. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
de Freitas AC, Gomes Leitão Mda C and
Coimbra EC: Prospects of molecularly-targeted therapies for
cervical cancer treatment. Curr Drug Targets. 16:77–91. 2015.
View Article : Google Scholar
|
|
5
|
Jakubowicz J, Blecharz P, Skotnicki P,
Reinfuss M, Walasek T and Luczynska E: Toxicity of concurrent
chemoradiotherapy for locally advanced cervical cancer. Eur J
Gynaecol Oncol. 35:393–399. 2014.PubMed/NCBI
|
|
6
|
Bazaeva IIa, Gorbunova VA, Kravets OA,
Khokhlova SV, Limareva SV, Panov VO, Strel’tsova ON and Tarachkova
EV: Chemoradiotherapy for locally advanced cervical cancer. Vopr
Onkol. 60:280–287. 2014.In Russian.
|
|
7
|
Butler MS: The role of natural product
chemistry in drug discovery. J Nat Prod. 67:2141–2153. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Paterson I and Anderson EA: Chemistry. The
renaissance of natural products as drug candidates. Science.
310:451–453. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsuda H, Ohshima Y, Nomoto H, Fujita K,
Matsuda E, Iigo M, Takasuka N and Moore MA: Cancer prevention by
natural compounds. Drug Metab Pharmacokinet. 19:245–263. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nobili S, Lippi D, Witort E, Donnini M,
Bausi L, Mini E and Capaccioli S: Natural compounds for cancer
treatment and prevention. Pharmacol Res. 59:365–378. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang WY, Cai YZ and Zhang Y: Natural
phenolic compounds from medicinal herbs and dietary plants:
Potential use for cancer prevention. Nutr Cancer. 62:1–20. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McCarty MF: Current prospects for
controlling cancer growth with non-cytotoxic agents - nutrients,
phytochemicals, herbal extracts, and available drugs. Med
Hypotheses. 56:137–154. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lazzeroni M, Gandini S, Puntoni M, Bonanni
B, Gennari A and DeCensi A: The science behind vitamins and natural
compounds for breast cancer prevention. Getting the most prevention
out of it. Breast. 20(Suppl 3): S36–S41. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moon DO, Choi YH, Moon SK, Kim WJ and Kim
GY: Butein suppresses the expression of nuclear factor-kappa
B-mediated matrix metalloproteinase-9 and vascular endothelial
growth factor in prostate cancer cells. Toxicol In Vitro.
24:1927–1934. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kojima R, Kawachi M and Ito M: Butein
suppresses ICAM-1 expression through the inhibition of IκBα and
c-Jun phosphorylation in TNF-α- and PMA-treated HUVECs. Int
Immunopharmacol. 24:267–275. 2015. View Article : Google Scholar
|
|
16
|
Rasheed Z, Akhtar N, Khan A, Khan KA and
Haqqi TM: Butrin, isobutrin, and butein from medicinal plant Butea
monosperma selectively inhibit nuclear factor-kappaB in activated
human mast cells: Suppression of tumor necrosis factor-alpha,
interleukin (IL)-6, and IL-8. J Pharmacol Exp Ther. 333:354–363.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee SH, Seo GS and Sohn DH: Inhibition of
lipopolysaccha-ride-induced expression of inducible nitric oxide
synthase by butein in RAW 264.7 cells. Biochem Biophys Res Commun.
323:125–132. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chan SC, Chang YS, Wang JP, Chen SC and
Kuo SC: Three new flavonoids and antiallergic, anti-inflammatory
constituents from the heartwood of Dalbergia odorifera. Planta Med.
64:153–158. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yit CC and Das NP: Cytotoxic effect of
butein on human colon adenocarcinoma cell proliferation. Cancer
Lett. 82:65–72. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Ma C, Qian M, Wen Z, Jing H and Qian
D: Butein induces cell apoptosis and inhibition of cyclooxygenase-2
expression in A549 lung cancer cells. Mol Med Rep. 9:763–767.
2014.
|
|
21
|
Cui Z, Song E, Hu DN, Chen M, Rosen R and
McCormick SA: Butein induces apoptosis in human uveal melanoma
cells through mitochondrial apoptosis pathway. Curr Eye Res.
37:730–739. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Khan N, Adhami VM, Afaq F and Mukhtar H:
Butein induces apoptosis and inhibits prostate tumor growth in
vitro and in vivo. Antioxid Redox Signal. 16:1195–1204. 2012.
View Article : Google Scholar :
|
|
23
|
Kim NY, Pae HO, Oh GS, Kang TH, Kim YC,
Rhew HY and Chung HT: Butein, a plant polyphenol, induces apoptosis
concomitant with increased caspase-3 activity, decreased Bcl-2
expression and increased Bax expression in HL-60 cells. Pharmacol
Toxicol. 88:261–266. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Chan FL, Chen S and Leung LK: The
plant polyphenol butein inhibits testosterone-induced proliferation
in breast cancer cells expressing aromatase. Life Sci. 77:39–51.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jang HS, Kook SH, Son YO, Kim JG, Jeon YM,
Jang YS, Choi KC, Kim J, Han SK, Lee KY, et al: Flavonoids purified
from Rhus verniciflua Stokes actively inhibit cell growth and
induce apoptosis in human osteosarcoma cells. Biochim Biophys Acta.
1726:309–316. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rajendran P, Ong TH, Chen L, Li F,
Shanmugam MK, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, et
al: Suppression of signal transducer and activator of transcription
3 activation by butein inhibits growth of human hepatocellular
carcinoma in vivo. Clin Cancer Res. 17:1425–1439. 2011. View Article : Google Scholar
|
|
27
|
Chen YH, Yeh CW, Lo HC, Su SL, Hseu YC and
Hsu LS: Generation of reactive oxygen species mediates
butein-induced apoptosis in neuroblastoma cells. Oncol Rep.
27:1233–1237. 2012.PubMed/NCBI
|
|
28
|
Yadav VR, Prasad S, Sung B and Aggarwal
BB: The role of chalcones in suppression of NF-κB-mediated
inflammation and cancer. Int Immunopharmacol. 11:295–309. 2011.
View Article : Google Scholar :
|
|
29
|
Kang DG, Lee AS, Mun YJ, Woo WH, Kim YC,
Sohn EJ, Moon MK and Lee HS: Butein ameliorates renal concentrating
ability in cisplatin-induced acute renal failure in rats. Biol
Pharm Bull. 27:366–370. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee SH, Choi WC, Kim KS, Park JW, Lee SH
and Yoon SW: Shrinkage of gastric cancer in an elderly patient who
received Rhus verniciflua Stokes extract. J Altern Complement Med.
16:497–500. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hamzeloo-Moghadam M, Aghaei M, Fallahian
F, Jafari SM, Dolati M, Abdolmohammadi MH, Hajiahmadi S and
Esmaeili S: Britannin, a sesquiterpene lactone, inhibits
proliferation and induces apoptosis through the mitochondrial
signaling pathway in human breast cancer cells. Tumour Biol.
36:1191–1198. 2015. View Article : Google Scholar
|
|
32
|
Moon DO, Kim MO, Choi YH, Hyun JW, Chang
WY and Kim GY: Butein induces G2/M phase arrest and
apoptosis in human hepatoma cancer cells through ROS generation.
Cancer Lett. 288:204–213. 2010. View Article : Google Scholar
|
|
33
|
Opletalova V, Jahodar L, Jun D and Opletal
L: Chalcones (1,3-diarylpropen-1-ones) and their analogs as
potential therapeutic agents in cardiovascular system diseases.
Ceska Slov Farm. 52:12–19. 2003.
|
|
34
|
Weerasinghe P, Hallock S, Tang SC and
Liepins A: Role of Bcl-2 family proteins and caspase-3 in
sanguinarine-induced bimodal cell death. Cell Biol Toxicol.
17:371–381. 2001. View Article : Google Scholar
|
|
35
|
Cory S and Adams JM: The Bcl2 family:
Regulators of the cellular life-or-death switch. Nat Rev Cancer.
2:647–656. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Valko M, Leibfritz D, Moncol J, Cronin MT,
Mazur M and Telser J: Free radicals and antioxidants in normal
physiological functions and human disease. Int J Biochem Cell Biol.
39:44–84. 2007. View Article : Google Scholar
|
|
37
|
Ali-Seyed M, Bhuvaneswari R, Soo KC and
Olivo M: Photolon™ - Photosensitization induces apoptosis via
ROS-mediated crosstalk between mitochondria and lysosomes. Int J
Oncol. 39:821–831. 2011.PubMed/NCBI
|
|
38
|
Yang LH, Ho YJ, Lin JF, Yeh CW, Kao SH and
Hsu LS: Butein inhibits the proliferation of breast cancer cells
through generation of reactive oxygen species and modulation of ERK
and p38 activities. Mol Med Rep. 6:1126–1132. 2012.PubMed/NCBI
|
|
39
|
Fresno Vara JA, Casado E, de Castro J,
Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling
pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen YL, Law PY and Loh HH: Inhibition of
PI3K/Akt signaling: An emerging paradigm for targeted cancer
therapy. Curr Med Chem Anticancer Agents. 5:575–589. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu SC, Chen C, Chung CH, Wang PC, Wu NL,
Cheng JK, Lai YW, Sun HL, Peng CY, Tang CH, et al: Inhibitory
effects of butein on cancer metastasis and bioenergetic modulation.
J Agric Food Chem. 62:9109–9117. 2014. View Article : Google Scholar : PubMed/NCBI
|
